| http://www.w3.org/ns/prov#value | - rug response, metabolism of drugs and biologics in children, and pediatric clinical trials; (ii)particular pediatric diseases, disorders or conditions where more complete knowledge and testing of therapeutics, including drugs and biologics, may be beneficial in pediatric populations; and (iii)the adequacy of necessary infrastructure to conduct pediatric pharmacological research, including research
|
